Diagnostic performance of CT, gadoxetate disodium-enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta-analysis
- PMID: 28901685
- DOI: 10.1002/jmri.25852
Diagnostic performance of CT, gadoxetate disodium-enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta-analysis
Abstract
Background: Imaging studies, including computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET), have an essential role in the detection and localization of colorectal liver metastasis (CRLM).
Purpose: To systematically determine the diagnostic accuracy of multidetector row CT (MDCT), gadoxetate disodium-enhanced MRI, and PET/CT for diagnosing CRLM and the sources of heterogeneity between the reported results.
Study type: Systematic review and meta-analysis.
Subjects: In all, 2151 lesions in CT studies, 2301 lesions in MRI studies, 1846 lesions in PET/CT studies, FIELD STRENGTH: 1.5T and 3.0T.
Assessment: We identified research studies that investigated MDCT, gadoxetate disodium-enhanced MRI, and PET/CT to diagnose CRLM by performing a systematic search of PubMed MEDLINE and EMBASE. Study quality was assessed using Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2).
Statistical tests: According to the types of imaging tests, study heterogeneity and the threshold effect were analyzed and the meta-analytic summary of sensitivity and specificity were estimated. Meta-regression analysis was performed to further investigate study heterogeneity.
Results: Of the 860 articles screened, we found 36 studies from 24 articles reporting a diagnosis of CRLM (11 CT studies, 12 MRI studies, and 13 PET/CT studies). The meta-analytic summary sensitivity for CT, MRI, and PET/CT were 82.1% (95% confidence interval [CI], 74.0-88.1%), 93.1% (95% CI, 88.4-96.0%), and 74.1% (95% CI, 62.1-83.3%), respectively. The meta-analytic summary specificity for CT, MRI, and PET/CT were 73.5% (95% CI, 53.7-86.9%), 87.3% (95% CI, 77.5-93.2%), and 93.9% (95% CI, 83.9-97.8%), respectively. There was no threshold effect in any of the imaging tests. Neoadjuvant chemotherapy significantly decreased the sensitivity of CT and MRI (P < 0.01), although it did not significantly affect the sensitivity of PET/CT. The study design, type of reference standard, and study quality also affected the diagnostic performances of imaging studies.
Data conclusion: Despite the heterogeneous accuracy between studies, gadoxetate disodium-enhanced MRI showed the highest sensitivity, and gadoxetate disodium-enhanced MRI and PET/CT had similar specificities for diagnosing CRLM.
Level of evidence: 3 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018;47:1237-1250.
Keywords: colon; computed tomography; magnetic resonance imaging; metastasis; positron emission tomography.
© 2017 International Society for Magnetic Resonance in Medicine.
Similar articles
-
Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI.Acta Radiol. 2016 Sep;57(9):1040-8. doi: 10.1177/0284185115617349. Epub 2015 Nov 29. Acta Radiol. 2016. PMID: 26622057
-
Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI, and FDG PET/CT: a meta-analysis.Acta Radiol. 2021 Mar;62(3):302-312. doi: 10.1177/0284185120925481. Epub 2020 Jun 6. Acta Radiol. 2021. PMID: 32506935
-
Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.Invest Radiol. 2011 Sep;46(9):548-55. doi: 10.1097/RLI.0b013e31821a2163. Invest Radiol. 2011. PMID: 21577131
-
Diagnostic performance of [18F]FDG-PET/MRI for liver metastasis in patients with primary malignancy: a systematic review and meta-analysis.Eur Radiol. 2019 Jul;29(7):3553-3563. doi: 10.1007/s00330-018-5909-x. Epub 2019 Feb 4. Eur Radiol. 2019. PMID: 30715585
-
PET/CT and MRI for Identifying Axillary Lymph Node Metastases in Breast Cancer Patients: Systematic Review and Meta-Analysis.J Magn Reson Imaging. 2020 Dec;52(6):1840-1851. doi: 10.1002/jmri.27246. Epub 2020 Jun 21. J Magn Reson Imaging. 2020. PMID: 32567090
Cited by
-
Comparison of 68Ga-DOTATATE Positron Emmited Tomography/Computed Tomography and Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases from Well-Differentiated Neuroendocrine Tumors.Curr Oncol. 2024 Jan 16;31(1):521-534. doi: 10.3390/curroncol31010036. Curr Oncol. 2024. PMID: 38248121 Free PMC article.
-
Chinese national clinical practice guidelines on the prevention, diagnosis, and treatment of early gastric cancer.Chin Med J (Engl). 2024 Apr 20;137(8):887-908. doi: 10.1097/CM9.0000000000003101. Epub 2024 Mar 21. Chin Med J (Engl). 2024. PMID: 38515297 Free PMC article.
-
Current status of surgical treatment of colorectal liver metastases.World J Clin Cases. 2018 Nov 26;6(14):716-734. doi: 10.12998/wjcc.v6.i14.716. World J Clin Cases. 2018. PMID: 30510936 Free PMC article. Review.
-
Clinical added value of MRI to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): study protocol for an international multicentre prospective diagnostic accuracy study.BMC Cancer. 2021 Oct 18;21(1):1116. doi: 10.1186/s12885-021-08833-1. BMC Cancer. 2021. PMID: 34663243 Free PMC article.
-
Cost-effectiveness analysis of MRI, CE-CT and 18F-FDG PET/CT for detecting colorectal liver metastases eligible for hepatic resection.Front Oncol. 2023 Jul 24;13:1161738. doi: 10.3389/fonc.2023.1161738. eCollection 2023. Front Oncol. 2023. PMID: 37554160 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials